Lessons from the COVID-19 Pandemic: Knowledge and Preventive Actions Among a Mexican Population Sample
Lessons from the COVID-19 Pandemic: Knowledge and Preventive Actions Among a Mexican Population Sample Lecciones de la pandemia de COVID-19: conocimiento y acciones preventivas de una muestra de población mexicana
How to Cite
Download Citation

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Show authors biography
Objectives: To evaluate the knowledge of the general population about the COVID-19 pandemic, including the disease and the preventive measures to reduce spreading of the virus undertaken by participants.
Methods: We conducted a cross-sectional study on a Mexican population sample during the period of March 20th to March 27th in Mexico, via a computer-based survey. We evaluated general knowledge about COVID-19 and the adherence to recommendations.
Results: A total of 2,577 participants completed the survey. Our results revealed an overall proper knowledge about the disease, with 76.2% having the proper knowledge about the disease, which was significantly correlated with age (r=0.15, p<0.001), socioeconomic status (r=0.06, p<0.003) and maximum academic level achieved by the study subjects (r=0.12, p<0.001).
Conclusions: Overall, people have good knowledge of COVID-19 and know about the specific public health recommendations, but a large proportion of people do not strictly follow these recommendations.
Article visits 492 | PDF visits 25
Downloads
- Tyrrell DA, Bynoe ML. Cultivation of viruses from a high proportion of patients with colds. Lancet. 1966; 1(7428):76–77. DOI: 10.1016/s0140-6736(66)92364-6
- Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Heal. 2020; 25(3):278–280. DOI: 10.1111/tmi.13383
- Schoeman D, Fielding BC. Coronavirus envelope protein: Current knowledge. Virol J. 2019; 16(1):1–22. . https://doi.org/10.1186/s12985-019-1182-0
- Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
- Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579(7798):270–273. http://dx.doi.org/10.1038/s41586-020-2012-7
- Battegay M, Kuehl R, Tschudin-Sutter S, Hirsch HH, Widmer AF, Neher RA. 2019-novel Coronavirus (2019-nCoV): estimating the case fatality rate - a word of caution. Swiss Med Wkly. 2020; 150:1-3. DOI: 10.4414/smw.2020.20203
- Zhang T, Wu Q, Zhang Z. Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak. Curr Biol. 2020; 30(7) 1346–1351. https://doi.org/10.1016/j.cub.2020.03.022
- Yuen KS, Ye ZW, Fung SY, Chan CP, Jin DY. SARS-CoV-2 and COVID-19: The most important research questions. Cell Biosci. 2020; 10(1):1–5. https://doi.org/10.1186/s13578-020-00404-4
- Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, et al. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA. 2020; 323(14):1406-1407. DOI: 10.1001/jama.2020.2565
- Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, et al. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) from a Symptomatic Patient. JAMA. 2020; 323(16): 1610-1612. DOI: 10.1001/jama.2020.3227
- Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-NCOV infection from an asymptomatic contact in Germany. N Engl J Med. 2020; 382(10):970–971. DOI: 10.1056/NEJMc2001468
- Anderson EL, Turnham P, Griffin JR, Clarke CC. Consideration of the Aerosol Transmission for COVID-19 and Public Health. Risk Anal. 2020; 40(5):902-907. DOI: 10.1111/risa.13500
- Klompas M, Baker MA, Rhee C. Airborne Transmission of SARS-CoV-2: Theoretical Considerations and Available Evidence. JAMA. 2020; 324(5):441-442. DOI:10.1001/jama.2020.12458
- Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020; 382:1787–1799. DOI: 10.1056/NEJMoa2001282
- Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020; 30(3):269–271. https://doi.org/10.1038/s41422-020-0282-0
- Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther. 2020; 14(1):58–60. DOI: 10.5582/ddt.2020.01012
- Colson P, Rolain JM, Raoult D. Chloroquine for the 2019 novel coronavirus SARS-CoV-2. Int J Antimicrob Agents. 2020; 55(3):10–11. DOI: 10.1016/j.ijantimicag.2020.105923
- Baron SA, Devaux C, Colson P, Raoult D, Rolain JM. Teicoplanin: an alternative drug for the treatment of COVID-19? Int J Antimicrob Agents. 2020; 55(4): 1-2. https://doi.org/10.1016/j.ijantimicag.2020.105944
- Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020; 56(1):1-2. https://doi.org/10.1016/j.ijantimicag.2020.105949
- Folegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020; 396(10249):467-478. DOI: 10.1016/S0140-6736(20)31604-4.
- Amanat F, Krammer F. SARS-CoV-2 Vaccines: Status Report. Immunity. 2020; 52(4):583-589. https://doi.org/10.1016/j.immuni.2020.03.007
- Comisión Nacional de los Salarios Mínimos (México), Secretaría de Trabajo y Previsión Social. Salarios Mínimos 2020. Ciudad de México: Comisión Nacional de los Salarios Mínimos (México), Secretaría de Trabajo y Previsión Social; 2020.
- Geldsetzer P. Knowledge and Perceptions of COVID-19 Among the General Public in the United States and the United Kingdom: A Cross-sectional Online Survey. Ann Intern Med. 2020; 173(3):157-160. DOI: 10.7326/M20-0912
- Modi PD, Nair G, Uppe A, Modi J, Tuppekar B, Gharpure AS, et al. COVID-19 Awareness Among Healthcare Students and Professionals in Mumbai Metropolitan Region: A Questionnaire-Based Survey. Cureus. 2020; 12(4).:1-18. DOI: 10.7759/cureus.7514
- Roy D, Tripathy S, Kar SK, Sharma N, Verma SK, Kaushal V. Study of knowledge, attitude, anxiety & perceived mental healthcare need in Indian population during COVID-19 pandemic. Asian J Psychiatr. 2020; 51:1-7. https://doi.org/10.1016/j.ajp.2020.102083
- Kebede Y, Yitayih Y, Birhanu Z, Mekonen S, Ambelu A. Knowledge, perceptions and preventive practices towards COVID-19 early in the outbreak among Jimma university medical center visitors, Southwest Ethiopia. PLoS One. 2020; 15(5):1-15. DOI: 10.1371/journal.pone.0233744
- Honarvar B, Lankarani KB, Kharmandar A, Shaygani M, Zahedroozgar M, Rahmanian-Haghighi MR, et al. Knowledge, attitudes, risk perceptions, and practices of adults toward COVID-19: a population and field-based study from Iran. Int J Public Health. 2020; 65(6):731-739. DOI: 10.1007/s00038-020-01406-2
- Siddiqui AA, Alshammary F, Amin J, Rathore HA, Hassan I, Ilyas M, et al. Knowledge and practice regarding prevention of COVID-19 among the Saudi Arabian population.